Evidence map›Paper›PMID 36309371›Full record

ArticleIn vivo (Athens, Greece)

Standardized

Buakotchaphan Jirabanjerdsiri, Nicharat Sriratanasak, Pasarapa Towiwat, Tassanee Prueksasit, Suchada Sukrong, Pithi Chanvorachote

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Buakotchaphan JirabanjerdsiriPharmaceutical Sciences and Technology Graduate Program, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Nicharat SriratanasakDepartment of Pharmacology and Physiology, Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Pasarapa TowiwatDepartment of Pharmacology and Physiology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.
Tassanee PrueksasitDepartment of Environmental Science, Faculty of Science, Chulalongkorn University, Bangkok, Thailand.
Suchada SukrongDepartment of Pharmacognosy and Pharmaceutical Botany, Center of Excellence in DNA Barcoding of Thai Medicinal Plants, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; suchada.su@chula.ac.th.
Pithi ChanvorachoteDepartment of Pharmacology and Physiology, Center of Excellence in Cancer Cell and Molecular Biology, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand; pithi.c@chula.ac.th.
Chulalongkorn University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimFine particulate matter (PM MATERIALS AND

methodsThe extract was standardized with rosmarinic acid. Effects of standardized T. laurifolia extract (STLE) (0-400 μg/ml) and PM

resultsPM

conclusionSTLE exhibits promising natural antioxidant activity against oxidative stress induced by PM

Indexed as

AcanthaceaeNF-E2-Related Factor 2AntioxidantsKelch-Like ECH-Associated Protein 1Oxidative StressParticulate MatterReactive Oxygen SpeciesSignal TransductionAntioxidantsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Particulate MatterReactive Oxygen Speciesair pollutionantioxidantsKeratinocytesNRF2p62particulate matterPM2.5Thunbergia laurifolia

Identifiers

PMID36309371
PMCPMC9677787
OpenAlexW4307838416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.